Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c1071 |
|---|---|
| Identifier | NCT05907330 |
| Trial Title | Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: CU104|DRUG: Placebo |
Participant Information
| Sponsor | Curacle Co., Ltd. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-06-01 |
|---|---|
| Primary Completion Date | 2026-02-28 |
| Completion Date | 2026-03-31 |